RK7.F LABORATORIO FARMAC.ERFO
- Market cap
- EUR 7.68M
- P/E
- 18.0x
- P/B
- 0.92x
- ROE
- 4.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is RK7.F undervalued?
Graham numberRK7.F trades 14.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
LABORATORIO FARMAC.ERFO fundamental analysis
No fundamental analysis for LABORATORIO FARMAC.ERFO yet.
LABORATORIO FARMAC.ERFO stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About LABORATORIO FARMAC.ERFO
Laboratorio Farmaceutico Erfo S.p.A. engages in the developing and production of food supplements in Italy. It provides therapeutic solutions for andrology, gastroenterology, gynecology, neurology, dentistry, orthopedics, and vascular therapeutic areas. Laboratorio Farmaceutico Erfo S.p.A. was founded in 2013 and is based in Villafranca Tirrena, Italy.
Full company profileLABORATORIO FARMAC.ERFO financial statements
LABORATORIO FARMAC.ERFO annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 4.82M | 4.72M | 5.93M | - | 9.66M |
| Gross Profit | 3.45M | 3.40M | 2.60M | - | 6.72M |
| Operating Income | 1.62M | 1.06M | 919K | 600K | 1.15M |
| EBITDA | - | 1.61M | 1.56M | - | 2.02M |
| Net Income | 1.17M | 716K | 554K | 367K | 382K |
| EPS | 0.13 | 0.08 | 0.06 | - | 0.04 |
| Balance Sheet | |||||
| Total Assets | 6.94M | 10.5M | 10.1M | - | 12.0M |
| Total Liabilities | 2.21M | 10.5M | 2.26M | - | 3.67M |
| Shareholders' Equity | 4.73M | 3.47M | 7.86M | - | 7.96M |
| Cash & Short-term Investments | 347K | 1.47M | 843K | - | 1.05M |
| Cash Flow | |||||
| Operating Cash Flow | 2.27M | 762K | 1.30M | 1.24M | 919K |
| Capital Expenditure | 243K | 1.18M | 1.45M | 0.00 | 2.56M |
| Free Cash Flow | 2.03M | -416K | -148K | 723K | -1.65M |
| Ratios | |||||
| ROE | 24.7% | 20.7% | 7.0% | - | 4.8% |
| ROA | 16.8% | 6.8% | 5.5% | - | 3.2% |
| Net Profit Margin | 24.2% | 15.2% | 9.3% | - | 4.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
LABORATORIO FARMAC.ERFO dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jul 1, 2024
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | EUR 166K | 0.02 | 30.0% |
| 2022 | EUR 558K | 0.06 | 78.0% |
| 2021 | EUR 2.15M | 0.24 | 184.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns LABORATORIO FARMAC.ERFO
- Insiders 61.40%
- Institutions 0.00%
- Public & others 38.60%
- Shares outstanding 8.51M
- Free float 2.99M
LABORATORIO FARMAC.ERFO company profile
- Company name
- LABORATORIO FARMAC.ERFO
- Ticker
- RK7.F
- ISIN
- IT0005497885
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 47
- Fiscal year end
- December
- Address
- Zona Artigianale Loc., Villafranca Tirrena, ME, Italy, 98049
- Phone
- 39 09 09 14 61 25
- Website
- erfo.it
About LABORATORIO FARMAC.ERFO
Laboratorio Farmaceutico Erfo S.p.A. engages in the developing and production of food supplements in Italy. It provides therapeutic solutions for andrology, gastroenterology, gynecology, neurology, dentistry, orthopedics, and vascular therapeutic areas. Laboratorio Farmaceutico Erfo S.p.A. was founded in 2013 and is based in Villafranca Tirrena, Italy.
LABORATORIO FARMAC.ERFO management
2- Dr. Alessandro CutePresident of the Board of Directors & CEO · born 1970
- Daniele TravisanoChief Financial Officer